Norges Bank Ligand Pharmaceuticals Inc Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

48 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$68.53 - $87.91 $5.15 Million - $6.61 Million
75,194 New
75,194 $6.34 Million
Q4 2023

Feb 09, 2024
BUY
$49.57 - $72.63 $5.31 Million - $7.79 Million
107,188 New
107,188 $7.66 Million
Q3 2023

Nov 13, 2024
BUY
$58.86 - $72.67 $8.12 Million - $10 Million
137,988 New
137,988 $8.27 Million
Q3 2023

Nov 13, 2023
SELL
$58.86 - $72.67 $7.49 Million - $9.25 Million
-127,267 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$69.53 - $79.33 $2.11 Million - $2.4 Million
30,283 Added 40.27%
105,477 $7.6 Million
Q2 2023

Aug 14, 2023
SELL
$69.53 - $79.33 $8.47 Million - $9.66 Million
-121,773 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$65.67 - $77.08 $8.68 Million - $10.2 Million
132,177 New
132,177 $9.72 Million
Q4 2022

Feb 14, 2023
BUY
$61.72 - $96.74 $8.95 Million - $14 Million
145,067 New
145,067 $9.69 Million
Q3 2022

Nov 13, 2023
BUY
$0.01 - $107.56 $1,272 - $13.7 Million
127,267 New
127,267 $11 Million
Q2 2022

Aug 14, 2023
BUY
$74.52 - $117.06 $9.07 Million - $14.3 Million
121,773 New
121,773 $10.9 Million
Q1 2022

May 12, 2023
SELL
$94.99 - $151.56 $1.8 Million - $2.88 Million
-18,986 Reduced 13.09%
126,081 $14.2 Million
Q1 2022

May 09, 2022
SELL
$94.99 - $151.56 $11.6 Million - $18.6 Million
-122,456 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$127.69 - $165.85 $15.6 Million - $20.3 Million
122,456 New
122,456 $18.9 Million
Q3 2021

Nov 14, 2022
BUY
$102.33 - $144.73 $9.8 Million - $13.9 Million
95,790 New
95,790 $13.3 Million
Q3 2021

Nov 05, 2021
SELL
$102.33 - $144.73 $5.58 Million - $7.89 Million
-54,513 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$113.03 - $155.64 $6.16 Million - $8.48 Million
54,513 New
54,513 $7.15 Million
Q2 2021

Aug 10, 2021
SELL
$113.03 - $155.64 $13 Million - $17.9 Million
-115,091 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$99.52 - $215.83 $11.5 Million - $24.8 Million
115,091 New
115,091 $17.5 Million
Q1 2021

May 07, 2021
SELL
$99.52 - $215.83 $13.4 Million - $29.1 Million
-134,704 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$80.55 - $106.05 $10.9 Million - $14.3 Million
134,704 New
134,704 $13.4 Million
Q4 2020

Feb 10, 2021
SELL
$80.55 - $106.05 $10.9 Million - $14.4 Million
-135,563 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$89.56 - $126.72 $12.1 Million - $17.2 Million
135,563 New
135,563 $12.9 Million
Q3 2020

Nov 10, 2020
SELL
$89.56 - $126.72 $16.4 Million - $23.2 Million
-182,782 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$68.28 - $123.65 $12.5 Million - $22.6 Million
182,782 New
182,782 $20.4 Million
Q2 2020

Aug 07, 2020
SELL
$68.28 - $123.65 $14.5 Million - $26.3 Million
-212,481 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$63.37 - $107.88 $13.5 Million - $22.9 Million
212,481 New
212,481 $15.5 Million
Q1 2020

May 08, 2020
SELL
$63.37 - $107.88 $14.4 Million - $24.5 Million
-226,729 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$96.94 - $113.59 $22 Million - $25.8 Million
226,729 New
226,729 $23.6 Million
Q4 2019

Feb 12, 2020
SELL
$96.94 - $113.59 $22.9 Million - $26.8 Million
-235,737 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$86.25 - $120.16 $20.3 Million - $28.3 Million
235,737 New
235,737 $23.5 Million
Q3 2019

Nov 08, 2019
SELL
$86.25 - $120.16 $20.3 Million - $28.3 Million
-235,737 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$107.38 - $129.34 $25.3 Million - $30.5 Million
235,737 New
235,737 $26.9 Million
Q2 2019

Aug 09, 2019
SELL
$107.38 - $129.34 $25.3 Million - $30.5 Million
-235,737 Closed
0 $0
Q4 2018

Mar 04, 2019
BUY
$128.36 - $272.13 $30.3 Million - $64.2 Million
235,737 New
235,737 $32 Million
Q4 2018

Feb 08, 2019
SELL
$128.36 - $272.13 $28.6 Million - $60.6 Million
-222,721 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$211.18 - $274.49 $47 Million - $61.1 Million
222,721 New
222,721 $61.1 Million
Q3 2018

Nov 09, 2018
SELL
$211.18 - $274.49 $44 Million - $57.2 Million
-208,449 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$150.77 - $207.98 $31.4 Million - $43.4 Million
208,449 New
208,449 $43.2 Million
Q2 2018

Jul 23, 2018
SELL
$150.77 - $207.98 $29.6 Million - $40.8 Million
-196,017 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$138.63 - $182.62 $27.2 Million - $35.8 Million
196,017 New
196,017 $32.4 Million
Q1 2018

May 09, 2018
SELL
$138.63 - $182.62 $24.4 Million - $32.2 Million
-176,117 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$128.36 - $147.04 $22.6 Million - $25.9 Million
176,117 New
176,117 $24.1 Million
Q4 2017

Feb 09, 2018
SELL
$128.36 - $147.04 $20.2 Million - $23.2 Million
-157,565 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$120.91 - $137.94 $19.1 Million - $21.7 Million
157,565 New
157,565 $21.5 Million
Q3 2017

Nov 07, 2017
SELL
$120.91 - $137.94 $19.1 Million - $21.7 Million
-157,565 Closed
0 $0
Q2 2017

Jul 24, 2018
BUY
N/A
3,551 Added 2.31%
157,565 $19.1 Million
Q1 2017

May 11, 2018
SELL
N/A
-37,893 Reduced 19.75%
154,014 $16.3 Million
Q3 2016

Nov 13, 2017
BUY
N/A
191,907
191,907 $0

Others Institutions Holding LGND

# of Institutions
257
Shares Held
18.2M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2.01B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email